Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CD70-targeted PET/ CT in the Diagnosis of Malignant Cancers

NCT06852638 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06852638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06852638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CD70-targeted PET/ CT in the Diagnosis of Malignant Cancers
Lead sponsor
RenJi Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
December 23, 2024
Completion date
December 23, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma, lymphoma, lymphoma, large b-cell, diffuse, mantle cell lymphoma, nasopharyngeal carcinoma, renal cancer, renal clear cell carcinoma